Table 1 of Pauly, Mol Vis 2011; 17:745-755. Table 1 of Pauly, Mol Vis 2011; 17:745-755.
Table 1. Benzalkonium chloride (BAC) and active compound content of the antiallergic eye drops tested.
Eye drops |
Active compound content |
BAC content |
|---|---|---|
| Ketotifen fumarate (Zaditen®; Novartis Pharma SAS,Rueil-Malmaison, France) | 0.025% | 0.01% |
| Olopatadine chlorhydrate (Opatanol®; Patanol®; Alcon, Ft. Worth, TX) | 0.1% | 0.01% |
| Epinastine chlorhydrate (Purivist®; Allergan, Irvin, CA) | 0.05% | 0.01% |
| Levocabastine chlorhydrate (Levophta®; Chauvin Bausch & Lomb, Montpellier, France) | 0.05% | 0.015% |
| Preservative-free ketotifen fumarate (Zalerg®; Thea, Clermont-Ferrand, France) | 0.025% | - |
| Preservative-free NAAGA (NAABAK®; Thea, Clermont-Ferrand, France) | 4.9% | - |
| Preservative-free sodium cromoglycate (Cromabak®; Thea, Clermont-Ferrand, France) | 2% | - |